Subscribe To
FLGT / Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript
![Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript](https://cdn.snapi.dev/images/v1/a/o/transcript28-2139512.jpg)
FLGT News
![Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript](https://cdn.snapi.dev/images/v1/a/o/transcript28-2139512.jpg)
By Seeking Alpha
November 3, 2023
Fulgent Genetics, Inc. (FLGT) Q3 2023 Earnings Call Transcript
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q3 2023 Earnings Call Transcript November 3, 2023 8:30 AM ET Company Participants Melanie Solomon - IR Ming Hsie more_horizontal
![Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates](https://cdn.snapi.dev/images/v1/r/o/default1-2007432.jpg)
By Zacks Investment Research
August 4, 2023
Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates
Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares more_horizontal
![Fulgent Genetics: Post-Pandemic Devaluing Appears Overdone Fulgent Genetics: Post-Pandemic Devaluing Appears Overdone](https://cdn.snapi.dev/images/v1/o/e/image-1451139438-1995864.jpg)
By Seeking Alpha
July 29, 2023
Fulgent Genetics: Post-Pandemic Devaluing Appears Overdone
Fulgent Genetics is a technology-driven company focused on clinical diagnostics and therapeutics, with recent expansion into precision medicine. FLGT' more_horizontal
![2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years 2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years](https://cdn.snapi.dev/images/v1/d/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7330482finvestor-talks-with-group-of-medical-professionalsjpgopresizew400h400-1903070.jpg)
By The Motley Fool
May 23, 2023
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
Certain biotechs that hit it big early during the pandemic are now undervalued. BioNTech is preparing for a rapid pace of new drug launches. more_horizontal
![What To Expect From Fulgent Genetics In 2023 What To Expect From Fulgent Genetics In 2023](https://cdn.snapi.dev/images/v1/e/k/image-1334095553-1888987.jpg)
By Seeking Alpha
May 14, 2023
What To Expect From Fulgent Genetics In 2023
We initiate our coverage of Fulgent Genetics with an "outperform" rating and a $42 target price for the next 12 months. The company is continuing its more_horizontal
![Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year?](https://cdn.snapi.dev/images/v1/p/e/medical9-1877363.jpg)
By Zacks Investment Research
May 8, 2023
Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year?
Here is how Fulgent Genetics, Inc. (FLGT) and Masimo (MASI) have performed compared to their sector so far this year. more_horizontal
![Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Tops Revenue Estimates Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Tops Revenue Estimates](https://cdn.snapi.dev/images/v1/f/t/medical22-1874527.jpg)
By Zacks Investment Research
May 5, 2023
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Tops Revenue Estimates
Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares more_horizontal
![Are Medical Stocks Lagging Fulgent Genetics (FLGT) This Year? Are Medical Stocks Lagging Fulgent Genetics (FLGT) This Year?](https://cdn.snapi.dev/images/v1/x/a/medical20-1834518.jpg)
By Zacks Investment Research
April 12, 2023
Are Medical Stocks Lagging Fulgent Genetics (FLGT) This Year?
Here is how Fulgent Genetics, Inc. (FLGT) and Harrow Health (HROW) have performed compared to their sector so far this year. more_horizontal